INZY

4.73

1.28% +0.06

Handel nachbörslich: 4.73

Inozyme Pharma Inc (INZY)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$4.67

Offen:

$4.67

24-Stunden-Volumen:

215.13K

Marktkapitalisierung:

$292.58M

Einnahmen:

Nettoeinkommen (Verlust:

$-71.17M

KGV:

-3.0516

EPS:

-1.55

Netto-Cashflow:

$-70.97M

1W Leistung:

+1.72%

1M Leistung:

-2.47%

6M Leistung:

+46.89%

1J Leistung:

-28.87%

1-Tages-Spanne:

$4.59

$4.74

52-Wochen-Spanne:

$2.689

$7.795

Inozyme Pharma Inc Stock (INZY) Company Profile

Firmenname

Inozyme Pharma Inc

Sektor

Healthcare (1211)

Branche

Biotechnology (697)

Telefon

Adresse

700 Technology Square, Floor 2, Cambridge

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-05-15

Neueste SEC-Einreichungen

INZY's Discussions on Twitter

Inozyme Pharma Inc Stock (INZY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-03-23	Hochstufung	Jefferies	Hold → Buy
2022-05-26	Eingeleitet	Jefferies	Hold
2022-02-07	Eingeleitet	H.C. Wainwright	Buy
2021-11-29	Eingeleitet	Needham	Buy
2020-08-18	Eingeleitet	BofA Securities	Buy
2020-08-18	Eingeleitet	Cowen	Outperform
2020-08-18	Eingeleitet	Piper Sandler	Overweight
2020-08-18	Eingeleitet	Wedbush	Outperform

Alle ansehen

Inozyme Pharma Inc Aktie (INZY) Neueste Nachrichten

Inozyme Pharma, Inc. (NASDAQ:INZY) Sees Significant Increase in Short Interest - Defense World

Defense World

Inozyme Pharma (NASDAQ:INZY) Receives “Buy” Rating from Needham & Company LLC - Defense World

Defense World

Q2 2024 Earnings Estimate for Inozyme Pharma, Inc. Issued By HC Wainwright (NASDAQ:INZY) - MarketBeat

MarketBeat

Wedbush Weighs in on Inozyme Pharma, Inc.'s Q1 2025 Earnings (NASDAQ:INZY) - MarketBeat

MarketBeat

Needham & Company LLC Reiterates Buy Rating for Inozyme Pharma (NASDAQ:INZY) - MarketBeat

MarketBeat

Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference - Yahoo Finance

Yahoo Finance

Finanzdaten der Inozyme Pharma Inc-Aktie (INZY)